Loading...
Ten Years of Experience with Biphasic Insulin Aspart 30: From Drug Development to the Latest Clinical Findings
Biphasic insulin aspart 30 (BIAsp 30) includes 30% soluble rapid-acting insulin aspart (IAsp) along with an intermediate-acting 70% protaminated IAsp that provides coverage of prandial and basal insulin in a single injection. As BIAsp 30 has been available internationally for 10 years, this review p...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3590411/ https://ncbi.nlm.nih.gov/pubmed/22818015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11635490-000000000-00000 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|